[SKYSTAR COMMENCES TESTING ON TWO ADDITIONAL NEW PRODUCT DOSAGE FORMS TO FURTHER EXPAND THE COMPANY’S PRODUCT LINES The new dosage forms projected to generate $5 million in additional revenue by fiscal 2011 XI'AN, CHINA – May 12, 2010 - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), The product testing process will ensure that the new dosage forms will adhere]
[SKYSTAR COMMENCES TESTING ON TWO ADDITIONAL NEW PRODUCT DOSAGE FORMS TO FURTHER EXPAND THE COMPANY’S PRODUCT LINES The new dosage forms projected to generate $5 million in additional revenue by fiscal 2011 XI'AN, CHINA – May 12, 2010 - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), The product testing process will ensure that the new dosage forms will adhere]
[Home Inns Reports First Quarter 2010 Financial Results Revenues Increased 28% Year over Year to RMB 683 Million Shanghai, May 11, 2010 First Quarter 2010 Financial Highlights Total revenues for the first quarter increased 28.3% year over year to RMB 682.9 million (US$100.0 million), exceeding the guidance range of RMB 650 million to RMB 670 million. Net]
[Home Inns Reports First Quarter 2010 Financial Results Revenues Increased 28% Year over Year to RMB 683 Million Shanghai, May 11, 2010 First Quarter 2010 Financial Highlights Total revenues for the first quarter increased 28.3% year over year to RMB 682.9 million (US$100.0 million), exceeding the guidance range of RMB 650 million to RMB 670 million. Net]
[Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2010 First Quarter Earnings Conference Call on Monday, May 17, 2010 at 9:30 a.m. ET XIANYANG, China, May 12, 2010 (Xinhua-PRNewswire-FirstCall) http://www.viavid.net http://viavid.net/dce.aspx?sid=00007582 http://www.microsoft.com/windows/windowsmedia/en/download/default.asp This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website at About Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary]
[Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2010 First Quarter Earnings Conference Call on Monday, May 17, 2010 at 9:30 a.m. ET XIANYANG, China, May 12, 2010 (Xinhua-PRNewswire-FirstCall) http://www.viavid.net http://viavid.net/dce.aspx?sid=00007582 http://www.microsoft.com/windows/windowsmedia/en/download/default.asp This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website at About Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary]
[SKYSTARMMENCES TESTING ON TWODITIONAL NEW PRODUCT DOSAGE FORMS TO FURTHER EXPAND THEMPANYS PRODUCT LINES The new dosage forms projected to generate $5 million inditional revenue by fiscal 2011 XI'AN, CHINA May 12, 2010 -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), The product testing process will ensure that the new dosage forms willhere to good manufacturing]
[China Digital TV Announces Unaudited First Quarter 2010 Results BEIJING, China, May 11, 2010 — China Digital TV Holding Co., Ltd. (NYSE: STV) (“China Digital TV” or the “Company”), the leading provider of conditional access (“CA”) systems to China’s Highlights for First Quarter 2010 · Net revenues in the first quarter of 2010 were US$14.0 million, above the high-end of] [Page 99.1 Press release, dated May 11, 2010 4 CHINA DIGITAL TV HOLDING CO., LTD.]
[Home Inns Reports First Quarter 2010 Financial Results Revenuesreased 28% Year over Year to RMB 683 Million Shanghai, May11, 2010 First Quarter 2010 Financial Highlights Total revenues for the first quarterreased 28.3% year over year to RMB 682.9million (US$100.0million), exceeding the guidance range of RMB 650million to RMB 670million.]
[Form 10-Q x For the Quarterly Period Ended March 31, 2010 OR o For the transition period from to Commission File No.: 001-34098 HONG KONG HIGHPOWER TECHNOLOGY, INC. Delaware 20-4062622 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) Building A1, Luoshan Industrial Zone, Shanxia, Pinghu, Longgang, Shenzhen, Guangdong, 518111, People’s Republic of China (86) 755-89686238 (COMPANY’S] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Dang Yu Pan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Hong Kong Highpower Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Henry Ngan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Hong Kong Highpower Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dang Yu Pan Chairman of the Board and Chief Executive Officer May 12, 2010 Henry Ngan Chief Financial Officer (Principal Financial and Accounting Officer) May 12, 2010 EX-32.1 4 v184511_ex32-1.htm]
